129 related articles for article (PubMed ID: 27693368)
21. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
22. Proton-pump inhibitors. Are the side effects something to worry about, or much ado about nothing?
Harv Health Lett; 2011 Apr; 36(6):4-5. PubMed ID: 21560281
[No Abstract] [Full Text] [Related]
23. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
24. [Proton pump inhibitors (PPI): may be not as harmless as believed].
Reinberg O
Rev Med Suisse; 2015 Sep; 11(485):1665-71. PubMed ID: 26540997
[TBL] [Abstract][Full Text] [Related]
25. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
Tjon JA; Pe M; Soscia J; Mahant S
Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
[TBL] [Abstract][Full Text] [Related]
27. [A patient with inflammatory arthralgia, paraesthesia and atrial fibrillation].
Vossen D; Nehls V
Z Rheumatol; 2020 Feb; 79(1):78-82. PubMed ID: 31776649
[TBL] [Abstract][Full Text] [Related]
28. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
29. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Doornebal J; Bijlsma R; Brouwer RM
Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
[TBL] [Abstract][Full Text] [Related]
30. Hypomagnesaemia and hypocalcaemia in a patient with systemic sclerosis: role of proton pump inhibitors.
Perez MO; Neves EF; Bortolai CB; Sampaio-Barros PD; Andrade DC; Seguro LP
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-225-7. PubMed ID: 25068521
[TBL] [Abstract][Full Text] [Related]
31. Hypomagnesemia and proton-pump inhibitors.
Famularo G; Gasbarrone L; Minisola G
Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
[TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
33. Noncompliance is an impact factor in the treatment of gastroesophageal reflux disease.
Domingues G; Moraes-Filho JP
Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):761-5. PubMed ID: 24754402
[TBL] [Abstract][Full Text] [Related]
34. Systematic review: hypomagnesaemia induced by proton pump inhibition.
Hess MW; Hoenderop JG; Bindels RJ; Drenth JP
Aliment Pharmacol Ther; 2012 Sep; 36(5):405-13. PubMed ID: 22762246
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitors as also inhibitors of atrial fibrillation.
Lin K; Chen X; Zhang L; Wang Y; Shan Z
Eur J Pharmacol; 2013 Oct; 718(1-3):435-40. PubMed ID: 23973848
[TBL] [Abstract][Full Text] [Related]
36. Gastric corpus polyps associated with Proton Pump Inhibitors therapy.
Yakoob J; Abbas Z; Jafri W; Ahmad Z
J Coll Physicians Surg Pak; 2008 Mar; 18(3):172-3. PubMed ID: 18460247
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
38. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
39. Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.
Steingoetter A; Sauter M; Curcic J; Liu D; Menne D; Fried M; Fox M; Schwizer W
BMC Gastroenterol; 2015 Sep; 15():111. PubMed ID: 26328588
[TBL] [Abstract][Full Text] [Related]
40. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
Chrysant SG; Chrysant GS
Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
